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Abstract
Skin lesions are common and range from acute inflammatory dermatoses,  such as
urticaria, to malignant melanoma, which may be life-threatening. When confronting
skin diseases, it is important that the maxillofacial surgeon collaborate with both the
dermatologist and pathologist. The clinical history, gross appearance, and course of any
disease are as important as the microscopic findings. In this chapter, we discuss the
more common skin lesions of the face.
Keywords: acute and chronic dermatoses, infectious, auto immune, blistering, skin le‐
sion
1. Introduction
In this chapter, the more common skin lesions of the face are discussed. These include the
following:
• Acute inflammatory dermatoses: urticaria, acute eczema dermatitis, and erythema multi‐
forme
• Chronic inflammatory dermatoses: psoriasis and lichen planus
• Infectious dermatoses:  bacterial infections (impetigo, cat-scratch disease), fungal infec‐
tions, and viral infections (herpes simplex, chickenpox, herpes zoster)
• Autoimmune diseases: systemic lupus erythematosus, chronic cutaneous (discoid) lupus
erythematosus, scleroderma, and angioedema
• Blistering (bullous) disorders: pemphigus, bullous pemphigoid, and dermatitis herpetifor‐
mis
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• Benign and premalignant epithelial lesions and nevi: melanocytic nevus, dysplastic nevus,
actinic keratosis, seborrheic keratosis, and keratoacanthoma
• Malignant epidermal tumors: basal cell carcinoma, squamous cell carcinoma, and malig‐
nant melanoma
• Miscellaneous: Sturge-Weber syndrome, Paederus dermatitis, and melasma
2. Acute inflammatory dermatoses
2.1. Urticaria
Urticaria (“hives”) is a common disorder mediated by localized mast cell degranulation, which
leads to dermal microvascular hyperpermeability. The resulting erythematous, edematous,
and pruritic plaques are termed “wheals”. In most cases, urticaria stems from an immediate
(type 1) hypersensitivity reaction in which antigens trigger mast cell degranulation by binding
to immunoglobulin E (IgE) antibodies displayed on the mast cell surface. The responsible
antigens include pollens, foods, drugs, and insect venom (Figure 1) [1].
Figure 1. Urticaria.
2.2. Acute eczematous dermatitis
“Eczema” is a clinical term that embraces a number of conditions with varied underlying
etiologies. New lesions take the form of red papules, often with overlying vesicles, that ooze
and become crusted. With persistence, these lesions develop into raised, scaling plaques. The
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nature and degree of these changes vary among the clinical subtypes, which include the
following:
• allergic contact dermatitis, which stems from topical exposure to an allergen;
• atopic dermatitis, which has traditionally been attributed to allergen exposure but is now
thought to stem from defects in keratinocyte barrier function, many with a genetic basis;
• drug-related eczematous dermatitis, a hypersensitivity reaction to a drug;
• photoeczematous dermatitis, in which eczema appears as an abnormal reaction to UV or
visible light;
• primary irritant dermatitis, which results from exposure to substances that chemically,
physically, or mechanically damage the skin.
In most cases, these skin lesions resolve completely when the offending stimulus is removed
or exposure is limited, stressing the importance of investigating the underlying cause. Only
contact dermatitis, the most common form, is considered here.
Contact dermatitis is triggered by exposure to an environmental contact sensitizing agent, such
as poison ivy, that chemically reacts with self-proteins (Figure 2) [2].
Figure 2. Acute eczematous dermatitis.
2.3. Erythema multiforme
Erythema multiforme is a self-limited, sometimes episodic, disease of the skin that may also
involve the mucous membranes. It is characterized by a pleomorphic eruption consisting of
erythematous macules, papules, urticarial plaques, vesicles, and bullae. Individual lesions may
evolve through a papular, vesicular, and target (iris) stage in which bullae surmount an
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erythematous maculopapule. Lesions tend to be distributed symmetrically with a predilection
for the extremities, particularly the hands.
In the past, erythema multiforme was classified into erythema multiforme minor and erythema
multiforme major, the latter being characterized by a severe and sometimes fatal illness in
which fever, systemic symptoms, and severe oral lesions were usually present. Stevens-
Johnson syndrome was also diagnosed in these severe cases with oral involvement. Recently,
an attempt has been made to distinguish Stevens-Johnson syndrome from erythema multi‐
forme major with mucosal lesions on the basis of their different cutaneous lesions and their
etiology; their mucosal lesions are similar. Stevens-Johnson syndrome is said to be character‐
ized by flat atypical target lesions or purpuric macules that are widespread or limited to the
trunk. Erythema multiforme major with mucosal lesions has typical or raised atypical target
lesions, located on the extremities and/or the face. With these definitions, Stevens-Johnson
syndrome is usually related to drugs and erythema multiforme to herpes or other infections.
Erythema multiforme major occurs in younger males, has frequent recurrences, and is marked
by mild fever, milder mucosal lesions, and a lack of association with collagen vascular diseases,
human immunodeficiency virus (HIV) infection, or cancer. Recent or recurrent herpes simplex
infection is the principal risk factor. The criteria used to distinguish the component diseases
that form this spectrum have been criticized on fundamental clinical differences between the
two related conditions. Stevens-Johnson syndrome is associated with systemic symptoms and
the involvement of internal organs, whereas erythema multiforme is not.
Toxic epidermal necrolysis has been widely regarded as a separate entity or as representing
the severe end of the spectrum of erythema multiforme major or Stevens-Johnson syndrome.
Some clinicians have arbitrarily diagnosed toxic epidermal necrolysis when blisters and
Figure 3. Erythema multiforme.
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peeling involved more than 30% of the total body surface area and Stevens-Johnson syndrome
when mucosal lesions were present and blistering involved less than 30% of the body surface
(Figure 3) [3–5].
3. Chronic inflammatory dermatoses
3.1. Psoriasis
Psoriasis is a chronic inflammatory dermatosis that appears to have an autoimmune basis. It
is a common disorder, affecting as many as 1% to 2% of people in the United States. Persons
of all ages may develop the disease. Approximately 15% of patients with psoriasis have
associated arthritis. Psoriatic arthritis may be mild or may produce severe deformities
resembling the joint changes seen in rheumatoid arthritis. It can affect any joint in the body
and may be symmetrical or unilateral only. In addition, psoriasis may also be associated with
myopathy, enteropathy, and AIDS. Psoriasis results from interactions of genetic and environ‐
mental factors. As in the case of many autoimmune diseases, it is linked to genes within the
HLA locus, most frequently affecting the skin of the elbows, knees, scalp, lumbosacral areas,
intergluteal cleft, and glans penis.
The typical lesion is a well-demarcated, pink to salmon-colored plaque covered by loosely
adherent silver-white scales (Figure 4) [6–8].
Figure 4. Psoriasis (before and after treatment).
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3.2. Lichen planus
Lichen planus, a relatively common eruption of unknown etiology, displays violaceous, flat-
topped papules that are usually pruritic. A network of fine white lines (Wickham striae) may
be seen on the surface of the papules. There is a predilection for the flexor surface of the wrists,
the trunk, the thighs, and the genitalia. Oral lesions are common; rarely, the esophagus is also
involved. Lesions localized to the vulva and eyelids have been reported. Lichen planus
localized to a radiation field may represent an isomorphic response. It has also developed in
a healed herpes zoster scar. Nail changes occur, and, as with oral lesions, these may be the only
manifestations of the disease. Clinical variants include atrophic, annular, hypertrophic, linear,
zosteriform erosive, oral, actinic, follicular, erythematous, and bullous forms. An eruptive
variant also occurs. Spontaneous resolution of lichen planus may occur and is usual within 12
months, although postinflammatory pigmentation may persist for some time afterwards.
Familial cases are uncommon, and rarely these are associated with HLA-D7. An association
with HLA-DR1 has been found in nonfamilial cases (Figure 5) [9–14].
Figure 5. Lichen planus.
4. Infectious dermatoses
4.1. Bacterial infection
4.1.1. Impetigo
Impetigo is a superficial infection of the skin that is caused by Staphylococcus aureus, alone or
in combination with Streptococcus pyogenes (group A, β-hemolytic). Two main patterns are seen:
Seventy percent of the cases are nonbullous impetigo, which typically demonstrates a mixture
of S. aureus and S. pyogenes, whereas bullous impetigo is less common and predominantly
caused by S. aureus. The term “impetigo” is derived from a Latin word meaning “attack”
because of its common presentation as a scabbing eruption. Intact epithelium normally is
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protective against infection; thus, most cases arise in damaged skin, such as preexisting
dermatitis, cuts, abrasions, or insect bites. Secondary involvement of an area of dermatitis has
been termed impetiginized dermatitis. An increased prevalence is associated with debilitating
systemic conditions, such as HIV infection, type 2 diabetes mellitus, and dialysis. Nonbullous
impetigo (impetigo contagiosa) is the more prevalent pattern and occurs most frequently on
the legs, with less common involvement noted on the trunk, scalp, and face. Facial lesions
usually develop around the nose and mouth. In an infrequent pattern of impetigo termed
ecthyma, the central area of the crust becomes necrotic and forms a deep indurated ulceration.
Weakness, fever, and diarrhea may be seen. Lymphadenopathy and cellulitis are unusual
complications. Meningitis and pneumonia are very rare but may lead to serious complications,
even death (Figure 6) [15, 16].
Figure 6. Impetigo.
4.1.2. Cat-scratch disease
Cat-scratch disease is an infectious disorder that begins in the skin but classically spreads to
the adjacent lymph nodes. This infection is the most common cause of chronic regional
lymphadenopathy in children, with an estimated 22,000 cases occurring annually in the United
States. The causative organism was initially named Rochalimaea henselae but was reclassified
as Bartonella henselae when the genera Bartonella and Rochalimaea were combined. Almost all
cases arise after contact with a cat. The spread of the infection between cats appears to occur
through cat fleas. The organism becomes an intraerythrocytic parasite and may be transmitted
to humans via saliva or from a scratch. Infection from other sources is highly unlikely, but the
disease rarely has been described in dogs, monkeys, porcupine quills, and thorns. Person-to-
person transmission has not been documented. Eighty percent of the cases occur in patients
younger than 21 years. Cat-scratch disease begins as a papule that develops in 3 to 14 days
along the initial scratch line. The lesion typically progresses through erythematous, vesicular,
and papular-crusted stages, with resolution usually occurring within 1 to 3 weeks. About the
time the skin lesion heals, lymph node changes arise and may be accompanied by fever or
malaise. In about half of the cases, a single node is involved. Multiple regional nodes are
affected in about 20%, and nodal enlargement is discovered in multiple sites in about 33%.
Suppuration is noted in approximately 10% of affected patients. The most frequently affected
nodes are those in the head and neck, axillary, epitrochlear, and groin regions. Although the
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vast majority of affected patients present with typical cat-scratch disease as described above,
a variety of systemic manifestations may be seen. Of these, prolonged fever of unknown origin
and hepatosplenic disease are the most common. Less common problems include cardiac,
hematologic, neurological, ocular, orthopedic, and pulmonary manifestations (Figure 7) [17].
Figure 7. Cat-scratch disease.
4.1.3. Cutaneous leishmaniasis
Cutaneous leishmaniasis is a chronic self-limited granulomatous disease of the skin usually
caused by Leishmania tropica. It is common in children. It is endemic in the Middle East, around
the Eastern Mediterranean, in North Africa, and in areas of Asia. The term ”Old World”
leishmaniasis has been used for such cases (Figure 8) [18, 19].
Figure 8. Cutaneous leishmaniasis.
4.2. Fungal infections
4.2.1. Mucormycosis
Mucormycosis is an opportunistic, frequently fulminant fungal infection that is caused by
normally saprobic organisms of the subphylum Mucoromycotina, including such genera as
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Absidia, Mucor, Rhizomucor, and Rhizopus. The presenting symptoms of rhinocerebral mucor‐
mycosis may be exhibited in several ways. Patients may experience nasal obstruction, bloody
nasal discharge, facial pain or headache, facial swelling or cellulitis, and visual disturbances
with concurrent proptosis. Symptoms related to cranial nerve involvement (e.g., facial
paralysis) are often present. With progression of the disease into the cranial vault, blindness,
lethargy, and seizures may develop, followed by death (Figure 9) [20].
Figure 9. Mucormycosis.
4.3. Viral infections
4.3.1. Herpes simplex virus
The two herpes simplex viruses (type 1 and type 2) are similar in structure and disease
mechanisms but differ in antigenicity, anatomical site predilection, and epidemiology.
Differences in envelope glycoproteins account for their distinct antigenicity. Nevertheless,
there is potential for antibody cross-reactivity and antibodies directed against one type may
decrease the likelihood or severity of infection with the other type. HSV-1 is spread predom‐
inantly through infected saliva or active perioral lesions of the oral, facial, and ocular areas.
The pharynx, intraoral mucosa, lips, eyes, and skin above the waist are involved most
frequently. Genital HSV-1 infection is uncommon, although recent studies have shown an
increase in the proportion of genital herpes caused by HSV-1 in developed nations. This trend
has been attributed to an increase in oral-genital sexual behavior and lower rates of nonsexual
HSV-1 acquisition in childhood. Primary infection refers to initial exposure of an individual
without antibodies to the virus. Primary infection with HSV-1 typically occurs at a young age,
often is asymptomatic, and usually does not cause significant morbidity. For symptomatic
cases, the usual incubation period is 3 to 9 days. After primary infection is established, the
virus is taken up by sensory nerves and transported to the associated sensory or, less fre‐
quently, autonomic ganglia where the virus remains in a latent state. The most common site
of latency for HSV-1 is the trigeminal ganglion. The virus uses the axons of the sensory neurons
to travel back to the skin or mucosa. Recurrent (secondary or recrudescent) infection occurs
with reactivation of the virus. Old age, ultraviolet light, physical or emotional stress, fatigue,
heat, cold, pregnancy, allergy, trauma, dental treatment, respiratory illnesses, fever, menstru‐
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ation, systemic diseases, and malignancy have been associated with reactivation. Symptomatic
recurrences are fairly common and affect the epithelium supplied by the sensory ganglion;
however, reactivation with asymptomatic viral shedding greatly exceeds clinically evident
recurrences. Spread to an uninfected host can occur from symptomatic active lesions or
asymptomatic viral shedding. In addition, the virus may spread to other sites in the same host
to establish residency at the sensory ganglion of the new location (Figure 10) [21, 22].
Figure 10. Herpes simplex virus.
4.3.2. Herpes zoster (shingles)
After primary infection with varicella virus (chickenpox), the virus is transported up the
sensory nerves and establishes latency in the dorsal root ganglia. Clinically evident herpes
zoster develops after reactivation of the virus, with involvement of the distribution of the
affected sensory nerve.
Immunosuppression, HIV infection, treatment with cytotoxic or immunosuppressive drugs,
radiation, malignancy, old age, alcohol abuse, stress (emotional or physical), and dental
manipulation are additional predisposing factors for reactivation. The long-term impact of
varicella virus vaccination on herpes zoster prevalence is controversial and presently under
evaluation. Interestingly, it is possible to develop herpes zoster by reactivation of either the
wild type or the vaccine strain virus, although the risk for vaccine strain zoster seems to be
much lower than that for wild-type zoster. The clinical features of herpes zoster can be grouped
into three phases: prodromal, acute, and chronic. During initial viral replication, ganglionitis
develops with resultant neuronal necrosis and severe neuralgia. This inflammatory reaction
is responsible for the prodromal pain present in more than 90% of cases. The virus travels
down the nerve (dermatome) and may be accompanied by fever, malaise, and headache.
Typically, one dermatome is affected, but involvement of two or more can occur. The thoracic
dermatomes are affected in about two thirds of the cases. This prodromal pain normally
precedes the acute phase rash by 1 to 4 days and, depending on which dermatome is affected,
may masquerade as sensitive teeth, otitis media, migraine headache, myocardial infarction, or
appendicitis.
The acute phase begins as the involved skin develops clusters of vesicles set on an erythema‐
tous base. The lesions tend to follow the path of the affected nerve and terminate at the midline.
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Within 3 to 4 days, the vesicles become pustular and ulcerate, with crusts developing after 7
to 10 days. The lesions are contagious until they crust, although the rate of varicella zoster
virus (VZV) transmission from herpes zoster lesions is lower than that from varicella lesions.
The exanthema typically resolves within 2 to 3 weeks in otherwise healthy individuals. On
healing, scarring with hypopigmentation or hyperpigmentation is not unusual. Infrequently,
there is dermatomal pain without development of a rash; this pattern is called zoster sine
herpete (zoster without rash). Ocular involvement is present in approximately 10% to 25% of
cases and can cause significant morbidity, including permanent blindness. The ocular mani‐
festations are highly variable and may arise from direct virus-mediated epithelial damage,
neuropathy, immune-mediated damage, or secondary vasculopathy. Lesions on the tip of the
nose (Hutchinson sign) indicate involvement of the nasociliary branch of the trigeminal nerve
and an increased risk for severe ocular infection. In these cases, referral to an ophthalmologist
is mandatory. Reactivation of VZV in the geniculate ganglion may cause Ramsay Hunt
syndrome, which is characterized by cutaneous lesions of the external auditory canal and
involvement of the ipsilateral facial and auditory nerves. Affected individuals may exhibit
facial paralysis as well as hearing deficits, vertigo, and other auditory and vestibular symp‐
toms. In addition, some patients may develop loss of taste in the anterior two thirds of the
tongue. By using PCR or serology, investigators have detected active VZV infections in
approximately 30% of patients thought to have Bell’s palsy. Similar associations also have been
demonstrated with HSV and EBV. These findings suggest an underlying viral cause for many
cases of “idiopathic” facial paralysis. Approximately 15% of patients progress to the chronic
phase of herpes zoster (termed postherpetic neuralgia), which is characterized by persistent
pain after resolution of the rash. In defining postherpetic neuralgia, there is a lack of consensus
regarding the duration of pain persistence following the rash, although many investigators
consider a minimum period of 1 to 3 months. Risk factors include female sex, older age, history
of prodromal pain, moderate to severe rash and/or pain during the acute phase, and ophthal‐
mic involvement (Figures 11 and 12) [23–27].
Figure 11. Chickenpox.
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Figure 12. Herpes zoster.
5. Autoimmune disease
5.1. Systemic lupus erythematosus (SLE)
SLE is an autoimmune disease involving multiple organs that is characterized by a vast array
of autoantibodies, particularly antinuclear antibodies (ANAs), in which injury is caused
mainly by deposition of immune complexes and binding of antibodies to various cells and
tissues. The disease may be acute or insidious in its onset and is typically a chronic, remitting,
relapsing, and often febrile illness. Injury to the skin, joints, kidney, and serosal membranes is
prominent. SLE predominantly affects women, with the female-to-male ratio being 9:1 (Figure
13) [28–30].
Figure 13. Systemic lupus erythematosus.
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5.2. Chronic cutaneous lupus erythematosus (CCLE)
Patients with CCLE usually have few or no systemic signs or symptoms, with lesions being
limited to skin or mucosal surfaces. The skin lesions of CCLE most commonly present as
discoid lupus erythematosus. They begin as scaly, erythematous patches that are frequently
distributed on sun-exposed skin, especially in the head and neck areas. Patients may indicate
that the lesions are exacerbated by sun exposure. With time, the lesions may heal spontane‐
ously in one area but only to appear in another area. The healing process usually results in
cutaneous atrophy with scarring and hypopigmentation or hyperpigmentation of the resolv‐
ing lesion (Figure 14) [31, 32].
Figure 14. Chronic cutaneous lupus erythematosus.
5.3. Systemic sclerosis (scleroderma)
Systemic sclerosis is autoimmunity of chronic inflammation with damage to small blood
vessels and perivascular fibrosis in the skin and multiple organs. The skin is most commonly
affected, but the gastrointestinal tract, kidneys, heart, muscles, and lungs also are frequently
involved. In some patients, the disease seems to remain confined to the skin for many years,
but in the majority, it progresses to visceral involvement with death from renal failure, cardiac
failure, pulmonary insufficiency, or intestinal malabsorption, in which the skin involvement
is often confined to the fingers, forearms, and face. Visceral involvement occurs late; hence,
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the clinical course is relatively benign. Some patients with the limited disease also develop a
combination of calcinosis, Raynaud’s phenomenon, esophageal dysmotility, sclerodactyly,
and telangiectasia, collectively called the CREST syndrome (Figure 15) [33].
Figure 15. Systemic sclerosis (scleroderma).
5.4. Angioedema (angioneurotic edema)
Angioedema is a diffuse edematous swelling of the soft tissues that most commonly involves
the subcutaneous and submucosal connective tissues but may affect the gastrointestinal or
respiratory tract, occasionally with fatal results. The disorder has been referred to as Quincke’s
disease, after the clinician who initially related the changes to an alteration in vascular
permeability. The outdated term angioneurotic edema also has been used because affected
patients often complained of a choking sensation and were labeled neurotic. The most common
cause is mast cell degranulation, which leads to histamine release and the typical clinical
alterations. IgE-mediated hypersensitivity reactions caused by drugs, foods, plants, dust, and
inhalants produce mast cell degranulation and are fairly common. Contact allergic reactions
to foods, cosmetics, topical medications, and even dental rubber dams have been found
responsible. Mast cell degranulation can even result from physical stimuli, such as heat, cold,
exercise, emotional stress, solar exposure, and significant vibration. Angioedema also can
result from activation of the complement pathway. This may be hereditary or acquired. Two
rare autosomal dominant hereditary forms are seen: type I and type II. Type I, comprising 85%
of the hereditary cases, is caused by a quantitative reduction in the inhibitor that prevents the
transformation of C1 to C1 esterase. Without adequate levels of C1 esterase inhibitor (C1-INH),
C1 esterase cleaves C4 and C2 and results in angioedema. Type II exhibits normal levels of C1-
INH, but the inhibitor is dysfunctional. The acquired type of C1-INH deficiency is seen in
association with certain types of lymphoproliferative diseases (Caldwell syndrome) or in
patients who develop specific autoantibodies. In lymphoproliferative diseases, monoclonal
antibodies directed against the tumor cells activate C1 and lead to consumption of C1-INH.
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An unusual pattern of drug reaction that can produce severe forms of angioedema that are not
mediated by IgE is the type associated with use of drugs called angiotensin-converting enzyme
(ACE) inhibitors (Figure 16) [34–36].
Figure 16. Angioedema.
6. Blistering (bullous) disorders
6.1. Pemphigus
Pemphigus is a rare autoimmune blistering disorder resulting from loss of normal intercellular
attachments within the epidermis and the squamous mucosal epithelium. There are three
major variants: pemphigus vulgaris (the most common type), pemphigus foliaceus, and
paraneoplastic pemphigus.
Pemphigus vulgaris is a rare disorder that occurs most commonly in the elderly and more
often in women than men. Lesions are painful, particularly when ruptured, and secondary
infections are common. Most cases are associated with oropharyngeal involvement at some
point in their course. Most patients require immunosuppressive therapy, sometimes for the
remainder of their lives. Medications can cause pemphigus, and when they do, patients most
often present with pemphigus foliaceus rather than pemphigus vulgaris. There is also an
unusual endemic form of pemphigus foliaceus in South America (fogo selvagem) that is
putatively associated with the bite of a black fly.
Pemphigus vulgaris, by far the most common type, involves both mucosa and skin, especially
on the scalp, face, axillae, groin, trunk, and points of pressure. The lesions are superficial flaccid
vesicles and bullae that rupture easily, leaving deep and often extensive erosions covered with
a serum crust.
Pemphigus foliaceus, a rare, more benign form of pemphigus, results in bullae confined to
skin, with only infrequent involvement of mucous membranes. The blisters in this disorder
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are superficial, such that more limited zones of erythema and crusting of ruptured blisters are
seen (Figure 17) [37–39].
Figure 17. Pemphigus vulgaris.
6.2. Bullous pemphigoid
Bullous pemphigoid is another distinctive acquired blistering disorder with an autoimmune
basis. Blistering in bullous pemphigoid is triggered by the linear deposition of IgG antibodies
and complement in the epidermal basement membrane. The bullae do not rupture as readily
as in pemphigus and, if uncomplicated by infection, heal without scarring. The disease tends
to follow a remitting and relapsing course and responds to topical or systemic immunosup‐
pressive agents. Gestational pemphigoid (also known as herpes gestationis, a misnomer) is a
clinically distinct subtype that appears suddenly during the second or third trimester of
pregnancy. It is also caused by autoantibodies against BPAG. It typically resolves after
childbirth but may recur with future pregnancies (Figure 18) [40].
Figure 18. Bullous pemphigoid.
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6.3. Dermatitis herpetiformis
Dermatitis herpetiformis is another type of autoimmune blistering disorder characterized by
extremely pruritic urticaria and grouped vesicles. The disease affects predominantly males,
often in the third and fourth decades of life. In up to 80% of cases, it occurs in association with
celiac disease; conversely, only a small minority of patients with celiac disease develop
dermatitis herpetiformis. Similar to celiac disease, dermatitis herpetiformis responds to a
gluten-free diet. The lesions of dermatitis herpetiformis are bilateral, symmetrical, and
grouped and preferentially involve the extensor surfaces, elbows, knees, upper back, and
buttocks. Initially, neutrophils accumulate selectively at the tips of dermal papillae, forming
small microabscesses. The basal cells overlying these microabscesses show vacuolization and
focal dermoepidermal separation that ultimately coalesce to form a true subepidermal blister
(Figure 19) [41].
Figure 19. Dermatitis herpetiformis.
7. Benign and premalignant epithelial lesions and nevi
7.1. Melanocytic nevinevus
Strictly speaking, the term “nevus” denotes any congenital lesion of the skin. Melanocytic
nevus, however, refers to any benign congenital or acquired neoplasm of melanocytes. There
are numerous types of melanocytic nevi, with varied appearances. Although these lesions
usually are of only cosmetic concern, they can become irritating or mimic melanoma, requiring
their surgical removal (Figure 20).
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Figure 20. Melanocytic nevus.
7.2. Dysplastic nevus
Dysplastic nevi may be sporadic or familial. The latter ones are important clinically because
they are considered potential precursors of melanoma. As with conventional melanocytic nevi,
activating NRAS or BRAF mutations are commonly found in dysplastic nevi and are believed
to have a pathogenic role. Unlike ordinary nevi, dysplastic nevi have a tendency to occur on
body surfaces not exposed to the sun as well as on sun-exposed sites. Familial dysplastic nevus
syndrome is strongly associated with melanoma, as the lifetime risk for the development of
melanoma in affected persons is close to 100%. In sporadic cases, only individuals with 10 or
more dysplastic nevi appear to be at an increased risk for melanoma (Figure 21) [42].
Figure 21. Dysplastic nevus.
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7.3. Actinic keratosis
Actinic keratosis is sun-damaged skin with hyperkeratosis that exposure to ionizing radiation,
industrial hydrocarbons, and arsenicals may induce similar lesions. Actinic keratoses are
usually less than 1 cm in diameter (Figure 22). The lips may also develop similar lesions
(termed “actinic cheilitis”) [43–47].
Figure 22. Actinic keratosis.
7.4. Seborrheic keratoseskeratosis
Seborrheic keratoses are characterized by round, flat, coin-like, and waxy plaques that vary in
diameter from millimeters to several centimeters and occur most frequently in middle-aged
individuals. They arise spontaneously and are particularly numerous on the trunk, although
the extremities, head, and neck may also be involved (Figure 23) [47, 48].
Figure 23. Seborrheic keratosis.
Common Skin Lesions of the Face
http://dx.doi.org/10.5772/63426
231
7.5. Keratoacanthoma
Keratoacanthoma is a self-limited epithelial proliferation with a strong clinical and histopa‐
thological similarity to well-differentiated squamous cell carcinoma. Indeed, many dermato‐
pathologists consider it to represent an extremely well-differentiated squamous cell
carcinoma. Cutaneous lesions presumably arise from the infundibulum of hair follicles. An
association with sun damage is suggested by the fact that most solitary lesions are found on
sun-exposed skin in older adults. Additional potential contributing factors include tar
exposure, HPV, immunosuppression, certain drugs (e.g., BRAF inhibitors and tyrosine kinase
inhibitors), tattooing, and burns or other trauma. Keratoacanthoma-like lesions have been
produced in animals by the cutaneous application of carcinogens. Keratoacanthoma shows a
male predilection and rarely occurs before 45 years of age. Almost 95% of solitary lesions
involve sun-exposed skin, and 8% of all cases involve the outer edge of the vermilion border
of the lips, with equal frequency on the upper and lower lips (Figure 24) [49, 50].
Figure 24. Keratoacanthoma.
8. Malignant epidermal tumors
8.1. Basal cell carcinoma
Basal cell carcinoma is the most common invasive cancer in humans, reaching nearly 1 million
cases per year in the United States. It is a slow-growing tumor that rarely metastasizes. The
vast majority of cases are recognized at an early stage and cured by local excision. However,
a small number of tumors (<0.5%) are locally aggressive and potentially disfiguring or
exceedingly rarely that they may metastasize to distant sites. They occur at sun-exposed sites
in lightly pigmented elderly adults. As with squamous cell carcinoma, the incidence of basal
cell carcinoma is increased in the setting of immunosuppression and in disorders of DNA
repair, such as xeroderma pigmentosum. Basal cell carcinomas usually present as pearly
papules containing prominent dilated subepidermal blood vessels (telangiectasias) (Figure
25) [51, 52].
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Figure 25. Basal cell carcinoma.
8.2. Squamous cell carcinoma
Squamous cell carcinoma is the second most common tumor arising on sun-exposed sites in
older people. The most important cause of cutaneous squamous cell carcinoma is DNA damage
induced by exposure to UV light. Other risk factors for squamous cell carcinoma include
industrial carcinogens (tars and oils), chronic ulcers and draining osteomyelitis, old burn scars,
ingestion of arsenicals, ionizing radiation, and (in the oral cavity) tobacco and betel nut
chewing (Figure 26) [53].
Figure 26. Squamous cell carcinoma.
8.3. Malignant melanoma
Melanoma is the most deadly of all skin cancers and is strongly linked to acquired mutations
caused by exposure to UV radiation in sunlight. It is a relatively common neoplasm that can
be cured if it is detected and treated when it is in its earliest stages. The great preponderance
of melanoma arises in the skin; other sites of origin include the oral and anogenital mucosal
surfaces (i.e., oropharynx as well as gastrointestinal and genitourinary tracts), esophagus,
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meninges, and the uvea of the eye. Today, as a result of increased public awareness of the signs
of cutaneous melanoma, most are cured surgically. Melanoma has two growth phases: radial
and vertical. Radial growth describes the horizontal spread of melanoma within the epidermis
and superficial dermis. During this initial stage, the tumor cells seem to lack the capacity to
metastasize. Tumors in radial growth phase fall into several clinicopathological classes,
including lentigo maligna, usually presenting as an indolent lesion on the face of older men
that may remain in the radial growth phase for several decades; superficial spreading, the most
common type of melanoma, usually involving sun-exposed skin; and acral/mucosal lentigi‐
nous melanoma, which is unrelated to sun exposure. In vertical growth phase, the tumor cells
invade downward into the deeper dermal layers as an expansile mass (Figures 27 and 28) [54–
57].
Figure 27. Melanoma.
Figure 28. Lentigo maligna melanoma.
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9. Miscellaneous
9.1. Sturge-Weber syndrome
Sturge-Weber syndrome is a rare, nonhereditary developmental condition that is characterized
by a hamartomatous vascular proliferation involving the tissues of the brain and face. Patients
with this disease are born with a dermal capillary vascular malformation of the face known as
a port-wine stain or nevus flammeus because of its deep purple color. This port-wine stain
usually has a unilateral distribution along one or more segments of the trigeminal nerve.
Occasionally, patients have bilateral involvement or additional port-wine lesions elsewhere
on the body. Only 8% to 10% of patients with facial port-wine nevi will have Sturge-Weber
syndrome. Risk for the condition occurs primarily in patients with involvement along the
distribution of the ophthalmic branch of the trigeminal nerve (V1). If the port-wine stain
involves the entire distribution of V1, the risk for neurological and ocular involvement is 78%
(Figure 29) [58–62].
Figure 29. Sturge-Weber syndrome.
9.2. Paederusderus dermatitis
Paederus dermatitis (also known as night burn) is a peculiar irritant dermatitis following
contact with an insect belonging to the genus Paederus and its fluid, which contains a blistering
toxic amide, the chemical pederin. The dermatitis is characterized by erythemato-bullous
lesions of sudden onset on exposed areas of the body: the neck is the most common site
involved, followed by the face (Figures 30 and 31) [63].
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Figure 30. Paederus dermatitis.
Figure 31. Paederus insect.
9.3. Melasma
Melasma is an acquired symmetrical hyperpigmentation of the sun-exposed skin of the face
and neck. Its exact cause is unknown, but UV light exposure and hormonal influences appear
to be important etiological factors. Studies suggest that UV light stimulates production of
dermal stem cell factor and α-melanocyte-stimulating hormone, resulting in proliferation of
melanocytes and increased melanin production. Melasma classically is associated with
pregnancy. In addition, an association with oral contraceptives, hormone replacement therapy,
thyroid disorders, phototoxic medications, antiepileptic agents, and cosmetics has been
described. Several studies suggest a genetic predisposition. The condition most commonly
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affects medium- to dark-complexioned persons—particularly Asian and Hispanic women. In
the United States, melasma affects more than 5 million individuals. It typically appears in adult
women as bilateral brown or grayish cutaneous macules that range from a few millimeters to
more than 2 cm in diameter. Lesions develop slowly with sun exposure and primarily involve
the skin of the midface, forehead, upper lip, chin, mandibular ramus region, and (rarely) the
arms. The pigmentation may remain faint or darken over time. Melasma only rarely affects
men (Figure 32) [64–68].
Figure 32. Melasma.
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